Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.46 |
| ▸ | LSS | P48449 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28424081 | 1.00 | DNM1 (0.48) | DNM1HTTSLC22A1LSSKMT2A | |
| SCHEMBL4598768 | 0.80 | SLC22A1 (0.33) | SLC22A1 | |
| Sulfuric Acid SCHEMBL2004006 | 0.79 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2AAPAF1 | |
| Sulfuric Acid SCHEMBL9698125 | 0.79 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2AAPAF1 | |
| Sulfuric Acid SCHEMBL711964 | 0.79 | HTT (0.71) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Sulfuric Acid SCHEMBL23248612 | 0.79 | HTT (0.71) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Sulfuric Acid SCHEMBL589212 | 0.79 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2AAPAF1 | |
| Sulfuric Acid SCHEMBL11744116 | 0.79 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2AAPAF1 | |
| Sulfuric Acid SCHEMBL6684704 | 0.79 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2AAPAF1 | |
| Sulfuric Acid SCHEMBL25278416 | 0.79 | HTT (0.71) | DNM1HTTKMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187414-B2 | Method to manufacture surface active compounds such as sulfate betaine | RHODIA OPERATIONS (FR) | 2015-11-17 | — | — | US | disclosed |
| US-20140343312-A1 | Novel method to manufacture surface active compounds such as sulfate betaine | RHODIA OPERATIONS a corporation | 2014-11-20 | — | — | US | disclosed |
| US-20020015925-A1 | Image forming material | KONICA CORPORATION (JP) | 2002-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343312-A1 | Novel method to manufacture surface active compounds such as sulfate betaine | SGMS2, SGMS1, SMS | DNM1 3712/4885HTT 3396/4885SLC22A1 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.